Partnership, Innovation Critical To Finding Quick Solutions To Disease Outbreaks

Forbes: Gates Foundation CEO: A Picture Of Hope In Early Ebola Vaccine Trials
Sue Desmond-Hellmann, CEO of the Bill & Melinda Gates Foundation

“…Ebola surely won’t be the last crisis we face. Tackling today’s era of global challenges will require the enormous innovative capacity of business. It will require bold new partnerships, such as the one we saw with this Ebola vaccine [now undergoing clinical trials]. Above all, it will require a commitment to ensuring that all people — no matter where they were born or how much they can pay — have access to the life-saving medicines they need. … When we act quickly and generously — when we commit to doing whatever it takes to save lives — we can achieve beautiful results” (1/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.